Prof. Dr. REYHAN NESLİHAN GÜRSOY

Yayın Ağı

Makaleler 30

1. Design, characterization, and in vitro/in vivo evaluation of HER2-targeted immunoliposomes co-functionalized with trastuzumab and iRGD for enhanced delivery of oxaliplatin in gastric cancer therapy

Fidan Y., Aras I. A., SİLİNDİR GÜNAY M., TİMUR S. S., ÖZTÜRK S., ESENDAĞLI G., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.113, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

2. Opioid Peptides: Pharmaceutical Significance and Formulation Approaches

Engin D., TİMUR S. S., Muçaj S., GÜRSOY R. N.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.43, sa.3, ss.243-260, 2023 (Scopus)

3. Recent advances in liposome-based targeted cancer therapy

Fidan Y., Muçaj S., TİMUR S. S., GÜRSOY R. N.

Journal of Liposome Research , 2023 (SCI-Expanded)

4. A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied using nanoformulations in permeability studies

REÇBER T., TİMUR S. S., ERDOĞAN KABLAN S., Yalcin F., Karabulut T. C., GÜRSOY R. N., et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS , cilt.214, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

5. The role of peptide-based therapeutics in oncotherapy

TİMUR S. S., GÜRSOY R. N.

JOURNAL OF DRUG TARGETING , cilt.29, sa.10, ss.1048-1062, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

6. Electrospun Nanofibers for Dual and Local Delivery of Neuroprotective Drugs

Haidar M. K., TİMUR S. S., Demirbolat G. M., NEMUTLU E., GÜRSOY R. N., ULUBAYRAM K., et al.

FIBERS AND POLYMERS , cilt.22, sa.2, ss.334-344, 2021 (SCI-Expanded)

7. Current status of micro/nanomotors in drug delivery

Tezel G., TİMUR S. S., KURALAY F., GÜRSOY R. N., ULUBAYRAM K., ÖNER L., et al.

JOURNAL OF DRUG TARGETING , cilt.29, sa.1, ss.29-45, 2021 (SCI-Expanded)

8. Design and in vitro evaluation of solid SEDDS for breast cancer therapy

TİMUR S. S., GÜRSOY R. N.

Journal of Drug Delivery Science and Technology , cilt.60, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

9. Composite nanofibers incorporating alpha lipoic acid and atorvastatin provide neuroprotection after peripheral nerve injury in rats

Haidar M. K., TİMUR S. S., Kazanci A., Turkoglu O. F., GÜRSOY R. N., NEMUTLU E., et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , cilt.153, ss.1-13, 2020 (SCI-Expanded, Scopus)

10. Atorvastatin-loaded nanosprayed chitosan nanoparticles for peripheral nerve injury

Haidar M. K., Demirbolat G. M., TİMUR S. S., GÜRSOY R. N., NEMUTLU E., ULUBAYRAM K., et al.

BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS , cilt.9, sa.2, ss.74-84, 2020 (SCI-Expanded)

11. Current Advances in Nanopharmaceuticals

Ozturk-Atar K., EROĞLU H., GÜRSOY R. N., ÇALIŞ S.

JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY , cilt.19, sa.7, ss.3686-3705, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

12. Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer

TİMUR S. S., Yoyen-Ermis D., Esendagli G., Yonat S., Horzum U., ESENDAĞLI G., et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , cilt.136, ss.138-146, 2019 (SCI-Expanded)

13. Molecular dynamics, thermodynamic, and mutational binding studies for tumor-specific LyP-1 in complex with p32.

Timur S. S., YALÇıN G., ÇEVIK Ö., ANDAÇ C., Gürsoy R. N.

Journal of biomolecular structure & dynamics , cilt.36, ss.1134-1144, 2018 (SCI-Expanded)

14. Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections.

TIMUR S. S., ŞAHIN A., AYTEKIN E., ÖZTÜRK N., POLAT K., TEZEL N., et al.

Pharmaceutical development and technology , cilt.23, ss.301-310, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-I in Human Breast Cancer

TİMUR S. S., Bhattarai P., GÜRSOY R. N., VURAL İ., Khaw B.

PHARMACEUTICAL RESEARCH , cilt.34, sa.2, ss.352-364, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Effect of topically applied sildenafil citrate on wound healing: experimental study

GURSOY K., ORUC M., KANKAYA Y., ULUSOY M. G., KOCER U., Kankaya D., et al.

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES , cilt.14, sa.3, ss.125-131, 2014 (SCI-Expanded)

17. Design, characterization and in vitro evaluation of SMEDDS containing an anticancer peptide, linear LyP-1

GÜRSOY R. N., Cevik O.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.19, sa.4, ss.486-490, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

18. Chitosan-based systems for intranasal immunization against foot-and-mouth disease

ÇOKÇALIŞKAN C., ÖZYÖRÜK F., GÜRSOY R. N., ALKAN M., GÜNBEYAZ M., Arca H. C., et al.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.19, sa.2, ss.181-188, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

19. Formulation and characterization of liquid crystal systems containing azelaic acid for topical delivery

AYTEKİN M., GÜRSOY R. N., İDE S., SOYLU E. H., HEKİMOĞLU S.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.39, sa.2, ss.228-239, 2013 (SCI-Expanded)

20. Kendiliğinden Emu lsifiye Olabilen İlaç Taşıyıcı Sistemler ve Farmasötik Alanda Uygulamaları

GÜRSOY R. N., Çevik Ö.

Hacettepe Üniversitesi Eczacılık Fakültesi Dergisi , 2011 (Hakemli Dergi)

21. Design and Characterization of Nanocrystal Formulations Containing Ezetimibe

Gulsun T., GÜRSOY R. N., ÖNER L.

CHEMICAL & PHARMACEUTICAL BULLETIN , cilt.59, sa.1, ss.41-45, 2011 (SCI-Expanded)

22. SWAXS Studies on Topical Lamellar Liquid Crystal Drug Delivery Systems

İDE S., Soylu E. H., Aytekin M., GÜRSOY R. N., Hekimoglu S.

ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES , cilt.66, 2010 (SCI-Expanded)

23. FORMULATION AND CHARACTERIZATION OF SURFACTIN-CONTAINING SELF-EMULSIFYING DRUG DELIVERY SYSTEMS

Kural F. H., GÜRSOY R. N.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.116-117, 2009 (SCI-Expanded)

24. Nanocrystal Technology for Oral Delivery of Poorly Water-Soluble Drugs

GÜLSÜN İNAL T., GÜRSOY R. N., ÖNER L.

FABAD Journal of Pharmaceutical Sciences , cilt.34, sa.1, ss.55-65, 2009 (Scopus)

25. Synthesis and chemical stability of a disulfide bond in a model cyclic pentapeptide: Cyclo(1,4)-Cys-Gly-Phe-Cys-Gly-OH

He H. T., Gursoy R. N., Kupczyk-Subotkowska L., TİAN J., WİLLİAMS T., Siahaan T. J.

JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.95, sa.10, ss.2222-2234, 2006 (SCI-Expanded)

26. Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain

KİLİC A. C., Capan Y., Vural I., Gursoy R. N., Dalkara T., CUİNE A., et al.

JOURNAL OF MICROENCAPSULATION , cilt.22, sa.6, ss.633-641, 2005 (SCI-Expanded)

27. Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor

AKTAŞ Y., ANDRİEUX K., ALONSO M. J., CALVO P., Gursoy R. N., COUVREUR P., et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.298, sa.2, ss.378-383, 2005 (SCI-Expanded)

28. Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system

Gursoy N., GARRİGUE J., RAZAFİNDRATSİTA A., LAMBERT G., BENİTA S.

JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.92, sa.12, ss.2411-2418, 2003 (SCI-Expanded)

29. Binding and internalization of an ICAM-1 peptide by the surface receptors of T cells

Gursoy R. N., SİAHAAN T.

JOURNAL OF PEPTIDE RESEARCH , cilt.53, sa.4, ss.414-421, 1999 (SCI-Expanded)

30. Separation and Analysis of Peptides and Proteins

HÜHMER A. F., ACED G. I., PERKİNS M. D., GÜRSOY R. N., JOİS D. S., LARİVE C., et al.

Analytical Chemistry , cilt.69, ss.29-58, 1997 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 27

1. In Vitro Cytotoxicity Study of Chitosan Nanoparticles Containing Atorvastatin Calcium For Treatment Of Peripheral Nerve Injury

HAİDAR M. K., DOĞAN S. S., GÜRSOY R. N., NEMUTLU E., DEMİRBOLAT G. M., ULUBAYRAM K., et al.

19th International Pharmaceutical Technology Symposium-IPTS 2018, 17 - 19 Eylül 2018, (Tam Metin Bildiri)

2. Application of A Novel Polymeric Electrospun Nanocomposite Incorporating Neuroprotective Drugs In Rat Sciatic Nerve Injury Model

HAİDAR M. K., Timur S. S., GÜRSOY R. N., NEMUTLU E., DEMİRBOLAT G. M., TÜRKOĞLU Ö. F., et al.

19th International Pharmaceutical Technology Symposium, 17 - 19 Eylül 2018, (Tam Metin Bildiri)

3. Development of Novel Polymeric Nanofibrous Composite Containing Nanoparticles For Dual And Localized Neuroprotective Drug Delivery

HAİDAR M. K., DOĞAN S. S., GÜRSOY R. N., NEMUTLU E., DEMİRBOLAT G. M., ULUBAYRAM K., et al.

19th International Pharmaceutical Technology Symposium-IPTS 2018, 17 - 19 Eylül 2018, (Tam Metin Bildiri)

4. The Effect of Temperature and pH on the Stability of Lymphatic Targeting Peptide, LyP-1

DOĞAN S. S., GÜRSOY R. N.

2017 AAPS Annual Meeting and Exposition, 12 - 15 Kasım 2017, (Özet Bildiri)

5. Design and in vitro/in vivo Evaluation of SMEDDS for Lymphatic Targeting Anticancer Peptide, LyP-1

DOĞAN S. S., GÜRSOY R. N.

2nd International Gazi Pharma Symposium Series (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri)

6. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer

DOĞAN S. S., Bhattarai P., GÜRSOY R. N., VURAL İ., Khaw B.

International Multidisciplinary Symposium on Drug Research and Development (DRD-2017), 5 - 07 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Stability Assessment of Lymphatic Targeting Peptide Cyclic LyP 1

DOĞAN S. S., GÜRSOY R. N.

2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016, (Özet Bildiri)

8. Potential of Peptide Drug Conjugates for Targeted Breast Cancer Therapy

DOĞAN S. S., Bhattarai P., GÜRSOY R. N., VURAL İ., Khaw B.

2016 AAPS National Biotechnology Conference, 16 - 18 Mayıs 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

9. In vitro Evaluation and Permeability Assessment of Liquid and Solid SMEDDS for the Lymphatic Targeting of the Cyclic LyP 1 Peptid

DOĞAN S. S., ÖZTÜRK N., ŞENER E., GÜRSOY R. N.

2015 AAPS Annual Meeting and Exposition, 25 - 29 Ekim 2015, (Özet Bildiri)

10. Design and Optimization of Solid SMEDDS for a Lymphatic Targeting Peptide LyP 1

DOĞAN S. S., GÜRSOY R. N.

2014 AAPS Annual Meeting and Exposition, 2 - 06 Ekim 2014, (Özet Bildiri)

11. Molecular Dynamics and Thermodynamic Studies of Tumor Specific Lyp 1 Peptide and Its Receptor p32

DOĞAN S. S., ÇEVİK ö., ANDAÇ A. C., GÜRSOY R. N.

2014 AAPS Annual Meeting and Exposition, 2 - 06 Ekim 2014, (Özet Bildiri)

12. Preparation and In vitro Evaluation of Furosemide Nanosuspensions for Enhancement of its Solubility and Permeability

GÜLSÜN İNAL T., sahand ebadi b., GÜRSOY R. N., VURAL İ., ŞAHİN S.

17th International Pharmaceutical Technology Symposium, Antalya, Türkiye, 8 - 10 Eylül 2014, (Özet Bildiri)

13. Ezetimib Nanokristallerinin Hazırlanması için Yöntem ve Farmasötik Formülasyonları

GÜLSÜN İNAL T., GÜRSOY R. N., ÖNER L.

2. Ege Ar-ge ve Teknoloji Günleri, İzmir, Türkiye, 28 - 30 Kasım 2012, (Özet Bildiri)

14. Preparation and Characterization of Furosemide Nanosuspensions

sahand ebadi b., GÜLSÜN İNAL T., GÜRSOY R. N., VURAL İ., ŞAHİN S.

AAPS Annual Meeting and Exposition, chicago, Amerika Birleşik Devletleri, 14 - 18 Ekim 2012, (Özet Bildiri)

15. Design, characterization and in vitro evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing an anticancer peptide, LyP-1

ÇEVİK Ö., GÜRSOY R. N.

2012 AAPS Annual Meeting and Exposition, Chicago, Amerika Birleşik Devletleri, 14 Ekim 2012, (Tam Metin Bildiri)

16. Preparation of Furosemide Nanosuspensions by High Pressure Homogenization and Its In vivo Characterization

GÜLSÜN İNAL T., sahand ebadi b., GÜRSOY R. N., VURAL İ., ŞAHİN S.

16th International Pharmaceutical Technology Symposium, Antalya, Türkiye, 10 - 12 Eylül 2012, (Özet Bildiri)

17. Nanokristal teknolojisi kullanılarak suda çözünürlüğü zayıf olan ezetimibin biyoyararlanımının artırılması

GÜLSÜN İNAL T., GÜRSOY R. N., ÖNER L.

Kimyevi Maddeler ve Mamülleri Sektöründe 1. AR-GE Proje Pazarı, İstanbul, Türkiye, 27 - 28 Aralık 2011, (Özet Bildiri)

18. Improving Dissolution Profile of Poorly Water soluble Drug Ezetimibe Using Nanocrystal Tablet Formulations

GÜLSÜN İNAL T., GÜRSOY R. N., ÖNER L.

FIP Pharmacutical Sciences 2010 World, Congress in association with the AAPS Annual Meeting and Exposition, new orleans, Amerika Birleşik Devletleri, 14 - 18 Kasım 2010, (Özet Bildiri)

19. Design And Characterization Of Tumor Specific Lyp-1 Peptide-Containing Smedds For The Lymphatic Targeting Of Solid Tumors İn Cancer Therapy

ÇEVİK Ö., GÜRSOY R. N.

2010 AAPS Annual Meeting and Exposition, New Orleans, Amerika Birleşik Devletleri, 14 Ekim 2010, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

20. Characterization of Nanocrystal Formulations Which Contain Poorly Water Soluble Drug Ezetimibe

GÜLSÜN İNAL T., GÜRSOY R. N., ÖNER L.

7th Central European Symposium on Pharmaceutical Technology & Biodelivery Systems, Ljubljana, Slovenya, 18 - 20 Eylül 2008

21. Improving Dissolution Profile of Ezetimibe

GÜLSÜN İNAL T., GÜRSOY R. N., ÖNER L.

EUFEPS Conference, When Variability Becomes an Issue in Drug Development: How to Understand, Predict and Manage?, Verona, İtalya, 13 - 14 Mayıs 2008, (Özet Bildiri)